Table 1.
Blood chemistry and haematology parameters assessed at baseline and end of treatment with everolimus.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | End of treatment | Baseline | End of treatment | Baseline | End of treatment | Baseline | End of treatment | |
| Creatinine (mg dL−1) | 1.00 | 1.20 | 0.90 | 0.80 | 0.84 | 0.81 | 1.13 | 0.90 |
| Triglycerides (mg dL−1) | 153 | 198 | 50 | 91 | 82 | 118 | 100 | 117 |
| Cholesterol (mg dL−1) | 195 | 195 | 167 | 207 | 138 | 175 | 195 | 203 |
| Haemoglobin (g dL−1) | 13.0 | 10.0 | 12.0 | 12.5 | 10.0 | 9.2 | 14.5 | 13.6 |
| Haematocrit (%) | 38.0 | 30.0 | 37.0 | 37.1 | 32.0 | 27.0 | 41.7 | 41.7 |
| Platelets (×103 µL−1) | 261 | 238 | 280 | 360 | 151 | 238 | 269 | 245 |